Patient attributes considered for decision-making with regard to adjuvant chemotherapy in early stage HR+, HER2-breast cancer patients: Results of the Multidisciplinary Application of Genomics in Clinical Practice (MAGIC) survey
Author(s):
Aapro, M.; Laurentiis, M. de; Mamounas, E.; Martin, M.; Rea, D.; Rouzier, R.; Smit, V.; Thomssen, C.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-03-31
Language
English
Is part of
European Journal of Cancer (2014), Vol. 50, p. S44-S45